Caption: CytoSMART Lux2 Duo Kit offers side-by-side comparisons between cell cultures. Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies today announced the launch of a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures. Said Jan-Willem van Bree, […]

Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital.  The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019. Further information on Oxford Nanopore’s fundraising will be made available after full closing. Oxford Nanopore’s sequencing devices are used […]

Logos Biosystems Launches the LUNA-FX7™ to Meet the Increased Demand for Greater Accuracy and Higher Throughput in Automated Cell Counters Logos Biosystems, a leading provider of innovative life science research tools, has launched the LUNA-FX7™, the newest and most advanced member of the SelectScience® award-winning LUNA™ Cell Counter Family. The LUNA-FX7™ combines accuracy, speed, flexibility […]

Denmark. The world leading HMOs producer, Glycom has been intensively using Lumex Instruments’ Capel capillary electrophoresis (CE) systems for the routine analysis of the fermentation liquid. Glycom has purchased its first Capel CE system to be used in the R&D lab for the determination of inorganic anions and some organic acids in fermentation liquid. The company is the world’s leading […]

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment […]

IP Group plc (LSE: IPO) (“IP Group” or “the Group” or “the Company”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore”), has announced that it is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. […]

Work supports rapid development of an innovative plasmid vaccine against COVID-19 Cytiva to provide instruments and consumables to support Takara Bio’s effort to support development of DNA vaccine with Osaka University and AnGes, Inc. group Cytiva (formerly part of GE Healthcare Life Sciences), a global provider of technologies and services that advance and accelerate the […]

Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market. San Carlos, CA and Seattle, WA, May 21, 2020 — Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that […]

HSINCHU, Taiwan — Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a patent infringement complaint in the Wuhan People’s Court in China against Pacific Biosciences of California, Inc. (“PacBio”). The complaint asserts that PacBio’s Sequel and Sequel II, as well as related commercialization activities by PacBio, its agents and certified service providers, infringe one or more […]